Related Experiment Video
Updated: May 31, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Effect of probiotics on allergic rhinitis in children; A systematic review and meta-analysis
Aida Bakhshi1,2, Farid Poursadegh3, Moeen Salari4
1Clinical Research Development Unit, Faculty of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Insights
Probiotics significantly improved nasal and eye symptoms and quality of life for children with allergic rhinitis (AR). However, results showed considerable variation, suggesting a potential adjunctive role requiring further high-quality research.
Area of Science:
- Pediatric Allergy and Immunology
- Gastroenterology
- Microbiome Research
Background:
- Allergic rhinitis (AR) is a common childhood condition impacting quality of life and increasing comorbidity risk.
- Probiotics are explored for their immunomodulatory potential in allergic diseases.
- This review assesses probiotic efficacy for pediatric AR.
Purpose of the Study:
- To evaluate the efficacy of probiotics versus placebo in managing pediatric allergic rhinitis.
- To analyze clinical and laboratory outcomes in children with AR receiving probiotic interventions.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searches across major databases (PubMed, Web of Science, Scopus, Embase) up to April 2025.
- Inclusion of RCTs in children (<18 years) comparing probiotics/prebiotics/synbiotics to placebo, analyzing clinical and lab parameters using random-effects models.
Main Results:
- Fourteen RCTs with 1,739 children were analyzed.
- Significant reductions in nasal symptom scores (SMD = -1.40) and eye symptom scores (SMD = -3.59) were observed.
- Quality of life (RQLQ) significantly improved (SMD = -2.98), with a minor increase in serum eosinophils (SMD = 0.29).
Conclusions:
- Probiotics demonstrated benefits for nasal/ocular symptoms and quality of life in pediatric AR.
- Findings should be interpreted cautiously due to substantial heterogeneity.
- Further standardized, high-quality trials are necessary to confirm probiotics' role as adjunctive therapy.
Background:
Allergic rhinitis (AR) is a prevalent chronic inflammatory disorder in children, often undiagnosed and associated with reduced quality of life and risk of comorbidities such as asthma. Probiotics have been found to be potential modulators of immune responses in allergic conditions. This systematic review and meta-analysis evaluated the efficacy of probiotics compared with placebo in the management of pediatric AR.
Methods:
Searches were conducted in accordance with a pre-registered protocol using MEDLINE (PubMed), the Web of Science, Scopus, and Embase through April 8, 2025. Randomized controlled trials (RCTs) of children aged < 18 years that compared probiotics, prebiotics, or synbiotics with a placebo were considered for inclusion. Outcomes of interest included clinical and laboratory parameters. Random-effects models with Hedges' g were used; heterogeneity was assessed via I2.
Results:
Fourteen RCTs involving 1,739 children were included. Meta-analysis revealed a significant reduction in nasal symptom scores (SMD = -1.40; 95% CI: -2.26 to -0.54; I2 = 91.3%) and eye symptom scores (SMD = -3.59; 95% CI: -5.84 to -1.33; I2 = 94.3%). Quality of life (RQLQ) was also significantly improved (SMD = -2.98; 95% CI: -4.85 to -1.12; I2 = 95.7%). Among laboratory markers, a small but significant increase in serum eosinophils was observed (SMD = 0.29; 95% CI: 0.06 to 0.52; I2 = 0%).
Conclusion:
Probiotics were associated with improvements in nasal and ocular symptoms and quality of life in children with AR; however, these findings should be interpreted with caution due to substantial heterogeneity across studies. Probiotics may have a potential role as an adjunctive therapy, but further high-quality, standardized trials are needed. PROSPERO registration code: CRD420250654461 on 24 February 2025. What is Known • Probiotics have been investigated as adjunctive therapy for pediatric allergic rhinitis because of their potential immunomodulatory effects. • Previous studies and meta-analyses have reported inconsistent findings regarding the clinical and immunological effects of probiotics in allergic rhinitis. What is New •This meta-analysis demonstrated significant improvements in nasal symptoms, ocular symptoms, and quality of life in children with allergic rhinitis receiving probiotics versus placebo. • Probiotic supplementation showed no consistent beneficial effects on immunological markers, while substantial heterogeneity remained across studies.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Probiotics
Asthma I: Introduction
Allergic Reactions
Microbiota Modulation by Antibiotics
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
